Cancer Gene Therapy Market, Size, Share, Outlook and Growth Opportunities 2019-2025
- ID:OGAMSC1908125
- Published: August-2021
- Pages:130
- OGAnalysis
Global Cancer Gene Therapy Market, Share, Size, Outlook and Growth Opportunities to 2025: By Therapy (Gene Transfer, Gene Induced Immunotherapy, and Oncolytic Virotherapy) and By Region
Key Findings
- Cancer Gene Therapy Market is set to register 32.6% CAGR over the forecast period 2019-2025.
- Major industry participants are adopting business expansion strategies.
- North America market share is increasing in cancer gene therapy market.
- High development cost of cancer drugs is hampering the market demand and sales.
High prevalence of cancers throughout the world along with the limited and painful existing cancer treatment regimen is mainly acting as cancer gene therapy market driver. Besides, the increasing government support in approving the cancer gene therapies will be a future market opportunity for industry players to improve their businesses
Moreover, the advancements in cancer therapy technologies leading to higher adoption rate and untapped markets in economies such as US, Canada and others are likely to provide new avenues for the market in near future.
Industry players are engaged in R&D in order to innovate new methods to treat life-threatening cancer diseases and obtaining approvals from government in order to add licence to their products.
North America is the leading regional market for cancer gene therapy, in terms of R&D activities, number of molecules approved for clinical usage, and revenue generation. In 2018 alone, FDA approved 3 molecules to treat cancer and inherited blindness in the US.
Further, modifications in terms of coverage by payers, market penetration, and government bodies are strongly impacting the market size and value. Nevertheless, high development cost of cancer drugs is expected to act as a restraint to the industry growth.
Global Cancer Gene Therapy Market Insights
Major trends shaping the near and long term future of the industry, opportunities, drivers and restraints of Cancer Gene Therapy market, detailed porter’s five forces analysis and competitive insights are included in the research report.
Global Cancer Gene Therapy Market Size by Therapy
The report presents the detailed annual outlook of each therapy of the Cancer Gene Therapy market to 2025. The report studied 3 therapies including gene transfer, gene induced immunotherapy, and oncolytic virotherapy. Among these therapies, gene transfer is estimated to be dominant therapy segment.
Global Cancer Gene Therapy Market Revenue by Region
The current Cancer Gene Therapy market share in terms of revenue across 5 regions including North America, Europe, Asia Pacific, South & Central America and Middle East & Africa are studied in the report. In addition, historic data from 2017 and annual forecasts to 2025 are also included in the research report. Globally, North America is the leading contributor to the Cancer Gene Therapy market.
Global Cancer Gene Therapy Market Analysis by Company
Top 10 leading companies in global Cancer Gene Therapy market are analyzed in the report along with their business overview, operations, geographical locations, financial analysis, SWOT profile and Cancer Gene Therapy products & services.
Global Cancer Gene Therapy Market News and Recent Developments
Latest news and industry developments in terms of Cancer Gene Therapy product expansions, acquisitions, organic & inorganic growth strategies, joint ventures and collaborations, product launches, market expansions etc are included in the report.
Scope:
Long term perspective on the Cancer Gene Therapy industry: 2018 (base year), 2019- 2025 (forecast period)
Cancer Gene Therapy Market- Forecasts by Segments- Therapy by geography.
- The report categorizes the global Cancer Gene Therapy market on the basis of therapy into 3 categories including gene transfer, gene induced immunotherapy, and oncolytic virotherapy.
- The report analyses the global Cancer Gene Therapy market across countries in 5 regions including Asia-Pacific, Europe, North America, South & Central America, and Middle East and Africa.
Cancer Gene Therapy Market- Strategic Analysis Review
- Key strategies opted by leading players
- Short to Long Term Industry Trends
- Porter’s Five Forces Analysis
- Supply side and Demand Side Drivers and Challenges
Cancer Gene Therapy Market- Growth Opportunities
- Potential New Business Opportunities
- Key Areas of Focus in forecast period
Cancer Gene Therapy Market- Competitive Scenario
- 10 companies are analysed in the report including Adaptimmune Therapeutics plc, GlaxoSmithKline (GSK), Bluebird bio, Inc., Merck, Celgene, Shanghai Sunway Biotech, BioCancell, Shenzhen SiBiono GeneTech, SynerGene Therapeutics, and OncoGenex Pharmaceuticals.
- Company Peer-to-Peer Comparison
- Company Profile and SWOT Analysis
- Financial Analysis
Table of Contents
1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Introduction to Global Cancer Gene Therapy Market
2.1 Global Cancer Gene Therapy Market Snapshot, 2018
2.2 Cancer Gene Therapy Industry Overview
2.3 Research Perspective
3. Global Cancer Gene Therapy Market- Strategic Analysis
3.1 Short Term and Long Term Industry Trends Affecting Global Cancer Gene Therapy Market
3.2 Leading Cancer Gene Therapy Types Targeted by Global Manufacturers
3.3 Key Consumption Patterns of Cancer Gene Therapy
3.4 Potential Markets Vital for business Expansion
3.5 Five Forces Analysis
3.6 Drivers and Restraints
4. Global Cancer Gene Therapy Market Outlook and Growth Opportunities by Therapy
4.1 Gene Transfer Market Outlook, 2019- 2025
4.2 Gene Induced Immunotherapy Market Outlook, 2019- 2025
4.3 Oncolytic Virotherapy Market Outlook, 2019- 2025
5. Asia Pacific Cancer Gene Therapy Market Outlook and Growth Opportunities
5.1 Key Findings, 2018
5.2 Asia Pacific Cancer Gene Therapy Market Outlook by Therapy, 2019- 2025
5.3 Asia Pacific Cancer Gene Therapy Market Outlook by Country, 2019- 2025
6. Europe Cancer Gene Therapy Market Outlook and Growth Opportunities
6.1 Key Findings, 2018
6.2 Europe Cancer Gene Therapy Market Outlook by Therapy, 2019- 2025
6.3 Europe Cancer Gene Therapy Market Outlook by Country, 2019- 2025
7. North America Cancer Gene Therapy Market Outlook and Growth Opportunities
7.1 Key Findings, 2018
7.2 North America Cancer Gene Therapy Market Outlook by Therapy, 2019- 2025
7.3 North America Cancer Gene Therapy Market Outlook by Country, 2019- 2025
8. South & Central America Cancer Gene Therapy Market Outlook and Growth Opportunities
8.1 Key Findings, 2018
8.2 South & Central America Cancer Gene Therapy Market Outlook by Therapy, 2019- 2025
8.3 South & Central America Cancer Gene Therapy Market Outlook by Country, 2019- 2025
9. Middle East & Africa Cancer Gene Therapy Market Outlook and Growth Opportunities
9.1 Key Findings, 2018
9.2 Middle East & Africa Cancer Gene Therapy Market Outlook by Therapy, 2019- 2025
9.3 Middle East & Africa Cancer Gene Therapy Market Outlook by Country, 2019- 2025
10. Competitive Landscape
10.1 Leading Players (Company Profile, SWOT Analysis, Cancer Gene Therapy Products, Financial Analysis)
10.1.1 Adaptimmune Therapeutics plc
10.1.2 GlaxoSmithKline (GSK)
10.1.3 Bluebird bio, Inc.
10.1.4 Merck
10.1.5 Celgene
10.1.6 Shanghai Sunway Biotech
10.1.7 BioCancell
10.1.8 Shenzhen SiBiono GeneTech
10.1.9 SynerGene Therapeutics
10.1.10 OncoGenex Pharmaceuticals
10.2 Company Benchmarking
10.3 Financial Analysis
11. Recent News and Deals Landscape
11.1 Mergers and Acquisitions
11.2 New Product Launches
11.3 Asset Transactions
11.4 Financial Announcements
12. Appendix
12.1 OGAnalysis Expertise
12.2 Sources and Research Methodology
12.3 Contact Information
| Type | Delivery Format | Details |
|---|---|---|
| Hard Copy | A printed copy of the report will be shipped to you. | |
| CD-ROM | The report will be shipped to you in CD ROM format. | |
| SINGLE USER Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows one specific user access to the product. |
| SITE LICENSE Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows all users within a given geographical location of your organization access to the product. |
| ENTERPRISEWIDE Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows all employees within your organization in different geographic locations access to the product. |
| 1 - 5 USERS Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows up to five users have access to the product. |
| 1 – 10 USERS Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows up to ten users have access to the product. |
| 1 – 15 USERS Electronic (PDF) | The report will be delivered to your email address in PDF format. | The license allows up to fifteen users have access to the product. |
| 1 - 5 USERS Online Access (For Databases) | Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. | The license allows up to five users have access to the product. |
| 1 - 10 USERS Online Access(For Databases) | Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. | The license allows up to ten users have access to the product. |
| 1 - 15 USERS Online Access(For Databases) | Database is accessed online through a secure website. You will receive a username and password via email to access to the online directory. | The license allows up to fifteen users have access to the product. |
| 1 - 5 USERS Electronic (Excel) | The Excel spreadsheet will be emailed to you. | The license allows up to five users have access to the product. |